Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C

被引:23
作者
Velusamy, Thirunavukkarasu [1 ]
Shetty, Praveenkumar [1 ]
Bhandary, Yashodhar P. [1 ]
Liu, Ming-Cheh [2 ]
Shetty, Sreerama [1 ]
机构
[1] Univ Texas Hlth Ctr Tyler, Dept Special Care Serv, Texas Lung Injury Inst, Tyler, TX 75708 USA
[2] Univ Toledo, Coll Pharm, Dept Pharmacol, Toledo, OH 43606 USA
关键词
D O I
10.1021/bi702338y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction of urokinase-type plasminogen activator (uPA) with its receptor, uPAR, is a key regulatory step in uPA-mediated cell proliferation and migration. Our previous studies demonstrated that posttranscriptional stabilization of uPAR mRNA by uPA contributes to the induction of cell surface uPAR expression, and heterogeneous nuclear ribonuclear protein C1 (hnRNPC) binds to a 110 nt sequence of uPAR mRNA 3'-UTR, thereby preventing its degradation. These observations indicate that hnRNPC could be involved in the induction of uPAR expression by uPA. In the present study, we investigated this possibility and confirmed that uPA increased the binding of hnRNPC to the 3'-UTR of uPAR mRNA. Furthermore, uPA induced tyrosine phosphorylation of hnRNPC and uPAR expression through mRNA stabilization. Inhibition of hnRNPC tyrosine phosphorylation abolished its interaction with uPAR mRNA and suppressed mRNA stabilization and cell surface uPAR expression. Deletion experiments revealed that hnRNPC binds to uPAR mRNA through its RNA binding domain (RBD). Site-directed mutagenesis studies further indicated that phosphorylation of tyrosine residue 57 (Y57) present in RBD of hnRNPC by uPA is essential for uPAR 3'-UTR mRNA binding and uPAR expression. Increased hnRNPC interaction with the uPAR mRNA 3'-UTR through phosphorylation of Y57 represents a novel mechanism by which uPA regulates posttranscriptional uPAR mRNA turnover and cell surface uPAR expression.
引用
收藏
页码:6508 / 6517
页数:10
相关论文
共 42 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]  
Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]   UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR, BETA-2-INTEGRINS, AND SRC-KINASES WITHIN A SINGLE RECEPTOR COMPLEX OF HUMAN MONOCYTES [J].
BOHUSLAV, J ;
HOREJSI, V ;
HANSMANN, C ;
STOCKL, J ;
WEIDLE, UH ;
MAJDIC, O ;
BARTKE, I ;
KNAPP, W ;
STOCKINGER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1381-1390
[6]  
BOOK CE, 2004, MED RES REV, V24, P13
[7]  
Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291
[8]  
CHAPMAN HA, 1994, FIBRINOLYSIS DIS, P253
[9]   THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION [J].
DANO, K ;
BEHRENDT, N ;
BRUNNER, N ;
ELLIS, V ;
PLOUG, M ;
PYKE, C .
FIBRINOLYSIS, 1994, 8 :189-203
[10]   Hyaluronic acid or TNF-α plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins [J].
Esnault, S ;
Malter, JS .
JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6780-6787